Jacksonville, May 13, 2025 (GLOBE NEWSWIRE) -- In This Article, You’ll Discover: TL;DR Summary: Silencil: Your Ultimate Guide to Tinnitus Relief Tinnitus, a condition that disrupts focus, sleep, and emotional stability for millions worldwide, is the focus of this article. We delve into Silencil, a dietary supplement formulated to support natural tinnitus relief through a…
NEW YORK, Sept. 21, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Sable Offshore Corp. (“Sable” or “the Company”) (NYSE: SOC) and certain of its officers.
DUBAI, United Arab Emirates, Sept. 21, 2025 (GLOBE NEWSWIRE) -- Mutuum Finance (MUTM), an Ethereum-based decentralized finance (DeFi) protocol, has raised over $16 million today. This traction is fueled by investor inflows supporting Mutuum Finance in its presale, backed by a completed CertiK smart contract audit, and its plans to launch a beta version of…
MILAN, Italy, Sept. 21, 2025 (GLOBE NEWSWIRE) -- LiTime, a global pioneer in new energy technology, made its first appearance at the 2025 Il Salone del Camper (September 13–21, Hall 02, Booth D006). The company showcased a lineup of best-selling flagship products and localized battery system solutions, with the spotlight on its H190 series of…
PARSIPPANY, N.J. and TEL AVIV, Israel, Sept. 20, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced the presentation of data from a real-world survey of patients taking AUSTEDO XR® (deutetrabenazine) extended-release tablets. Patients taking AUSTEDO XR reported increased social and emotional well-being as…
NEW YORK, Sept. 20, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Novo Nordisk A/S (NYSE: NVO) between May 7, 2025 and July 28, 2025, both dates inclusive (the “Class Period”), of the important September 30, 2025 lead plaintiff deadline.
